Endometrial morphology and modulation of hormone receptors during ovarian stimulation for assisted reproductive technology cycles

被引:17
|
作者
Detti, Laura [1 ]
Saed, Ghassan M. [2 ]
Fletcher, Nicole M. [2 ]
Kruger, Michael L. [2 ]
Brossoit, Michelle [3 ]
Diamond, Michael P. [3 ]
机构
[1] Univ Tennessee, Dept Obstet & Gynecol, Hlth Sci Ctr, Div Reprod Endocrinol & Infertil, Memphis, TN 38103 USA
[2] Wayne State Univ, CS Mott Ctr Human Dev, Detroit, MI USA
[3] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI USA
基金
美国国家卫生研究院;
关键词
Endometrial development; ART; hormone receptors; GnRH antagonist; real-time RT-PCR; ultrasound; HUMAN CHORIONIC-GONADOTROPIN; GENE-EXPRESSION; PHASE ENDOMETRIUM; OOCYTE RETRIEVAL; MATURATION; PROGESTERONE; IMPLANTATION; ANTAGONISTS; THICKNESS; IVF;
D O I
10.1016/j.fertnstert.2010.12.025
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To study the biochemical and morphologic implications of different hormonal levels on endometrial development during assisted reproductive technology (ART) cycles. Design: Prospective, controlled study. Setting: University center. Patient(s): Eleven women during a natural cycle (controls) and 11 oocyte donors during an ART cycle (treated). Intervention(s): At the time consistent with day-3 ET, a transvaginal ultrasound, an endometrial biopsy, and blood sampling were performed. Morphology and thickness of the endometrial stripe were recorded. Real-time reverse transcriptase-polymerase chain reaction was used to measure messenger RNA (mRNA) levels for estrogen receptor (ER)-alpha, ER-beta, P receptor (PR)-A, and PR-B in the endometrial tissue. Main Outcome Measure(s): To evaluate morphologic and biochemical endometrial development. Result(s): Endometrium was mostly trilaminar (proliferative-like pattern) and thicker in the treated group, as opposed to homogeneous and thinner in the controls. The PR-B mRNA expression increased 41% in treated patients; PR-A mRNA expression, instead, was unchanged. Serum E-2 and P were higher in the treated group than in controls. In contrast, FSH and LH levels were lower in the treated group. Conclusion(s): When compared with natural cycles, exposure of the endometrium to high hormone levels during ovarian stimulation significantly increased PR-B receptor expression at the time of ET. Concurrently, a proliferative-like endometrial pattern persisted. These findings reflect a delayed endometrial development in ART. (Fertil Steril (R) 2011;95:1037-41. (C) 2011 by American Society for Reproductive Medicine.)
引用
收藏
页码:1037 / 1041
页数:5
相关论文
共 50 条
  • [21] The use of anti-Mullerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling
    Pilsgaard, Fie
    Grynnerup, Anna G. -A.
    Lossl, Kristine
    Bungum, Leif
    Pinborg, Anja
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2018, 97 (09) : 1105 - 1113
  • [22] Risk of preeclampsia in pregnancies after assisted reproductive technology and ovarian stimulation
    Martin, Angela
    Monsour, Michael
    Boulet, Sheree
    Kawwass, Jennifer
    Kissin, Dmitry
    Jamieson, Denise
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2015, 212 (01) : S371 - S372
  • [23] Risk of Preeclampsia in Pregnancies After Assisted Reproductive Technology and Ovarian Stimulation
    Angela S. Martin
    Michael Monsour
    Jennifer F. Kawwass
    Sheree L. Boulet
    Dmitry M. Kissin
    Denise J. Jamieson
    Maternal and Child Health Journal, 2016, 20 : 2050 - 2056
  • [24] Impact of gonadotrophin stimulation for assisted reproductive technology on ovarian ageing and menopause
    Elder, Kay
    Mathews, Thomas
    Kutner, Ellen
    Kim, Eujin
    Espenberg, Donna
    Faddy, Malcolm
    Gosden, Roger
    REPRODUCTIVE BIOMEDICINE ONLINE, 2008, 16 (05) : 611 - 616
  • [25] Current Therapeutic Options for Controlled Ovarian Stimulation in Assisted Reproductive Technology
    Racca, Annalisa
    Drakopoulos, Panagiotis
    Raquel Neves, Ana
    Polyzos, Nikolaos P.
    DRUGS, 2020, 80 (10) : 973 - 994
  • [26] Current Therapeutic Options for Controlled Ovarian Stimulation in Assisted Reproductive Technology
    Annalisa Racca
    Panagiotis Drakopoulos
    Ana Raquel Neves
    Nikolaos P. Polyzos
    Drugs, 2020, 80 : 973 - 994
  • [27] Risk of Preeclampsia in Pregnancies After Assisted Reproductive Technology and Ovarian Stimulation
    Martin, Angela S.
    Monsour, Michael
    Kawwass, Jennifer F.
    Boulet, Sheree L.
    Kissin, Dmitry M.
    Jamieson, Denise J.
    MATERNAL AND CHILD HEALTH JOURNAL, 2016, 20 (10) : 2050 - 2056
  • [28] The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles
    Yang, Chunxia
    Dong, Naijun
    Li, Feng
    Ji, Yurong
    Pan, Yu
    She, Hong
    JOURNAL OF OVARIAN RESEARCH, 2022, 15 (01)
  • [29] The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles
    Chunxia Yang
    Naijun Dong
    Feng Li
    Yurong Ji
    Yu Pan
    Hong She
    Journal of Ovarian Research, 15
  • [30] Subendometrial resistence and pulsatility index assessment of endometrial receptivity in assisted reproductive technology cycles
    R. Silva Martins
    A. Helio Oliani
    D. Vaz Oliani
    J. Martinez de Oliveira
    Reproductive Biology and Endocrinology, 17